Detalhe da pesquisa
1.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
N Engl J Med
; 380(25): 2395-2405, 2019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157962
2.
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 379(2): 111-121, 2018 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860917
3.
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
Support Care Cancer
; 29(5): 2509-2517, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929540
4.
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer.
Cancer
; 126(13): 3084-3093, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315091
5.
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Cancer
; 125(17): 2945-2954, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090930
6.
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
Oncologist
; 24(6): 762-771, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30552158
7.
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
N Engl J Med
; 373(21): 2005-14, 2015 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412349
8.
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.
Cancer Discov
; 14(2): 290-307, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37791898
9.
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.
Cancer Res Commun
; 4(4): 1120-1134, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687247
10.
The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
Breast J
; 24(3): 424-425, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29251377
11.
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).
Melanoma Res
; 31(2): 162-172, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661190
12.
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
J Natl Cancer Inst
; 113(4): 390-399, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32986828
13.
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
JCO Precis Oncol
; 52021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476329
14.
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
JAMA Oncol
; 6(3): 367-374, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566680
15.
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307.
J Natl Cancer Inst
; 112(7): 698-707, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31693129
16.
Informed Consent and Decision Making Among Participants in Novel-Design Phase I Oncology Trials.
J Oncol Pract
; 13(10): e863-e873, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28837373
17.
A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignancies.
Invest New Drugs
; 24(6): 499-508, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16788861